Medical recommendations

Cellular therapy (also called cell therapy) with biopreparations of stem cells can provide positive effect in age-related and post-traumatic pathologies:

  • Cardio-vascular diseases: myocardial infarction, cerebral atherosclerosis, hypertension, ischemic heart disease, neurocirculatory dystonia.
  • System connective tissue diseases: rheumatoid arthritis, system vasculitis, systemic lupus erythematosus, system sclerodermia, rheumatism.
  • Respiratory diseases: bronchial asthma, bronchitis, chronic pneumonia.
  • Gastro-intestinal diseases: stomach and duodenal ulcer, non-specific ulcer colitis, cholecystitis, pancreatitis, colitis.
  • Liver diseases: cirrhosis, infection and toxic hepatitis, acute and chronic hepatorenal insufficiency, chronic hepatitis.
  • Renal and urinary tract diseases: pyelonephritis, cystitis, urethritis, urolothiasis.
  • Endocrine diseases: insulin-dependent diabetes, insulin-independent diabetes, hypothyroidism, pancreatic insufficiency, complications of diabetes, endocrine disorders.
  • Obstetric and gynecology: premature delamination of normally disposed placenta, premature delivery, gestational toxicosis, miscarriage, fetus hypotrophy, immune conflict, endometriosis, sterility, climacterim, climacteric neurosis, genital chronic inflammatory diseases.
  • Neurological diseases: hemicrany, infantile cerebral paralysis, diencephalic syndrome, neuralgia, neuritis, polyneuropathy, radiculopathy, consequences of cranio-cerebral trauma, encephalitis and stroke.
  • Oncological diseases of central nervous system.
  • Cerebral atrophic processes of different genesis.
  • Epilepsy and convulsive syndrome in children and adults.
  • Consequences of cerebral and spinal cord strokes.
  • Huntington's chorea, ataxia.
  • Atherosclerosis, disseminated sclerosis with spinal cord affection.
  • Parkinson’s disease, Alzheimer’s disease, Down’s disease, Strümpell's (Bechterew's) disease.
  • Severe cerebral and spinal cord traumas.
  • Surgical diseases: osteomyelitis, fractures (long-term clinical course), reconstructive surgery on bone tissue, in different traumas and surgical interventions.
  • Malignant diseases.
  • Immunodeficiency.
  • AIDS
  • Infection diseases.
  • Allergic diseases and autoimmune diseases.
  • Blood diseases: anemia, leucopenia, thrombocytopenia, leucosis, hemoblastosis.
  • Dermal diseases: psoriasis, oczema, trophic ulcers, decubital ulcers, neurodermitis, consequences of sex-transmitted diseases.
  • Eye diseases
  • Ear, throat and nose diseases
  • Dental and oral diseases.
  • Psychic diseases and sexual disorders: depression, irritability, aggressiveness, apathy, sleep and memory disorders.
  • Sexual pathology in men and women: impotency, sterility, potency and libido reduction.
  • Long-term chronic diseases of internal organs.
  • Gerontology.
  • Rejuvenation: vital tonus increase, delay of premature aging, life prolongation, quality of life improvement.

Contraindications for biopreparations treatment are very, if not exclusively, rare. Although, taking this into consideration, the treatment should start after throughout preliminary medical examination by the method that was specially developed.

Before taking decision for treatment it is necessary to study strong allergic reactions and preceding cases of anaphylactic reactions to administration of all medicines (antibiotics, solutions and anesthetics).

Special indication

After cellular preparation injection it is not recommended to take cytostatics, antimetabolites, antibiotics and other preparations that can cause intoxication and suppress stem cells activity during one month. One should deviate from this statement only due to vital indications.

Cellular therapy is compatible with all forms of therapy and, as a rule, does not cause complications and paradoxical reactions.

Treatment results are significantly facilitated in combined non-medicamentous therapy.

Ministry of Health of Ukraine License series AB ¹049870 dated 22.03.2006
Ministry of Health of Ukraine License series ÀÂ ¹511037 dated 03.12.2009
© Institute of Cellular Therapy 2004-2010.